Please find the link below to his winning abstract as published in the Heart Lung and Circulation Journal, August 2022.
2022 Cardiovascular Nursing Prize Winner Interview
Please find the link below to her winning abstract as published in the Heart Lung and Circulation Journal, August 2022.
Kristel Janssens, Baker Heart and Diabetes Institute
Modest association between peak exercise blood pressure and ambulatory hypertension in endurance athletes.
2022 Ralph Reader Prize Winner in Basic and Translational Science Interview
Please find the link below to his winning abstract as published in the Heart Lung and Circulation Journal, August 2022.
2022 Ralph Reader in Basic and Translational Science Prize Winner:
Dr Dinesh Selvakumar, Westmead Institute for Medical Research.
Change Over 70 Years of Cardiac Society of Australia and New Zealand
CSANZ Immediate Past President, Prof Clara Chow and President, Prof Stephen Nicholls have co-written this Editorial, “Change over 70 years of Cardiac Society of Australia and New Zealand”, now available in September’s issue of Heart Lung and Circulation.
“2022 marks the 70th year of the Cardiac Society of Australia and New Zealand (CSANZ). Change punctuates our 70th year as we emerge from a global pandemic and embrace a Society that has grown in diversity in membership, leadership, and activity. These changes are exemplified by our first virtual Annual Scientific Meeting in 2021 and firsts in women leadership—CSANZ President (Clara Chow) and Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) President elect (Emily Granger)…
Link to full article on HLC online. Full Text Here (HTML).
and download PDF
Change Over 70 Years of Cardiac Society of Australia and New Zealand
CSANZ Immediate Past President, Prof Clara Chow and President, Prof Stephen Nicholls have co-written this Editorial, “Change over 70 years of Cardiac Society of Australia and New Zealand”, now available in September’s issue of Heart Lung and Circulation.
“2022 marks the 70th year of the Cardiac Society of Australia and New Zealand (CSANZ). Change punctuates our 70th year as we emerge from a global pandemic and embrace a Society that has grown in diversity in membership, leadership, and activity. These changes are exemplified by our first virtual Annual Scientific Meeting in 2021 and firsts in women leadership—CSANZ President (Clara Chow) and Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) President elect (Emily Granger)…
Link to full article on HLC online. Full Text Here (HTML).
and download PDF
TGA Statutory Advisory Committees for 2023
The Therapeutic Goods Administration (TGA) is seeking applications from professionals with expertise in relevant medical or scientific fields or consumer health issues to support their statutory advisory committees. These include:
- Advisory Committee on Medical Devices
- Advisory Committee on Medicines
- Advisory Committee on Vaccines
Read more about the committee roles here.
Applications close at 11.30pm (AEST) this Sunday 4 September 2022.
CSANZ Daily Highlights Session at ESC Congress | 27 August
CSANZ will be presenting a Daily Highlights session at the ESC Congress on Saturday, 27 August. The session will be hosted by Stephen Nicholls, Will Parsonage, Julie Redfern and Elizabeth Paratz.
If you are in Barcelona, you can attend the session at the Global Stage in the Global Community area at 10.15am.
For those of us back home in Australia and New Zealand, the session will be available to watch online on the Global Community dedicated section of the ESC Congress platform.
Complimentary restricted access to ESC Congress 2022
The restrictive access will enable you to enter these areas on the congress digital platform:
Research Gateway – abstracts and clinical cases. Comment, share and like on your favourites. Open from 22 August with all the Moderated ePosters, complemented with oral abstracts and clinical cases after the sessions and until 12 September.
Global Community – connect with your National Cardiac Society to network, discuss the science in a local context, and catch up with colleagues. Open from 22 August to 12 September.
Click this link to get your complimentary restricted access.
For full access to ESC Congress, registration is required as usual. Click here.
Congratulations to the 2022 CSANZ ASM Ralph Reader Prize winners
2022 Ralph Reader Prize in Basic and Translational Science
Winner: Dinesh Selvakumar, Westmead Institute for Medical Research
Abstract: Cellular Heterogeneity in Human Pluripotent Stem Cell Derived Cardiomyocyte Grafts are responsible for Arrhythmias and are Treatable with Pharmacotherapy and Catheter Ablation
Read article in full here as published in the Heart Lung and Circulation Journal.
Judges: Jonathan Kalman, Louise Burrell, Rebecca Ritchie and Len Kritharides
2022 Ralph Reader Prize in Clinical Science
Winner: Julia Isbister, Centenary Institute
Abstract: Cellular Heterogeneity in Human Pluripotent Stem Cell Derived Cardiomyocyte Grafts are Responsible for Arrhythmias and are Treatable with Pharmacotherapy and Catheter Ablation
Read article in full here as published in the Heart Lung and Circulation Journal.
Judges: Ralph Stewart, Derek Chew, Gemma Figtree, Julie Redfern
2022 CSANZ ASM Prize winners
Congratulations to all the 2022 ASM Prize Winners
Allied Health, Science and Technology Prize
Winner: Adam Livori, Ballarat Health Services
Assessment of Telehealth Cardiology Pharmacist Clinic in Improving Therapy Adherence following Acute Coronary Syndrome and PCI.
Read abstract in full as published in Heart Lung and Circulation Journal.
Judges: Judith Katzenellenbogen, Andrew Maiorana, Katrina Poppe
Cardiac Imaging Prize
Winner: Aaisha Ferkh, Westmead Hospital
Echocardiographic deep phenotyping of hypertrophic cardiomyopathies: amyloid, Anderson-Fabry and hypertensive heart disease.
Read abstract in full as published in Heart Lung and Circulation Journal.
Judges: Selwyn Wong, Raj Puranik, Rebecca Kozor
Cardiovascular Nursing Prize
Winner: Kristel Janssens, Baker Heart and Diabetes Institute
Modest association between peak exercise blood pressure and ambulatory hypertension in endurance athletes.
Read abstract in full as published in Heart Lung and Circulation Journal.
Judges: Patricia Davidson, Kimberley Bardsley, Christopher Lee
Heart Failure Prize
Winner: David Chieng, Baker Heart and Diabetes Institute
Catheter ablation in atrial fibrillation and heart failure with preserved ejection fraction improves peak pulmonary capillary wedge pressure, exercise capacity and quality of life. A Prospective Randomised Controlled Trial (RCT-STALL HFpEF).
Read abstract in full as published in Heart Lung and Circulation Journal.
Judges: Andrew Sindone, Rob Doughty, Theresa McDonagh
Heart Rhythm Prize
Winner: Ahmed Al-Kaisey, Royal Melbourne Hospital
Polygenic risk scores identify atrial electrophysiological substrate abnormalities and predict atrial fibrillation recurrence following catheter ablation.
Read abstract in full as published in Heart Lung and Circulation Journal.
Judges: Andrew Martin, Livia Hool, Karen Phillips
Indigenous Health Prize
Winner: Keriana Kingi-Nepe, Gisborne Hospital NZ
The impact of Sacubitril-Valsartan on Te Tairāwhiti (Gisborne and East Coast) region.
Read abstract in full as published in Heart Lung and Circulation Journal.
Judges: Alex Brown, Karen Brewer
Paediatric and Congenital Cardiology Prize
Winner: Elizabeth Paratz, Baker Heart and Diabetes Institute
Prevalence of coronary artery anomalies in young sudden cardiac death: insights from a prospective state-wide registry.
Read abstract in full as published in Heart Lung and Circulation Journal.
Judges: Clare O’Donnell, Mugur Nicolae
Prevention Prize
Winner: Louise Segan, Baker Heart and Diabetes Institute
Development and validation of the HARMS2-AF lifestyle risk score to predict incident AF.
Read abstract in full as published in Heart Lung and Circulation Journal.
Judges: David Colquhoun, Julie Redfern, Robyn Gallagher
2022 CSANZ ASM New Investigator Poster Prizes
Medical Student Poster Prize
Winner: Angus Fung, UNSW
Title: Prognostic association supports indexing size measures in echocardiography by body surface area.
Judges: Peter Psaltis and Dominica Zentner
Basic Physician Trainee or Advanced Trainee Poster Prize
Winner: Gavin Huangfu, Fiona Stanley Hospital
Title: CT evaluation of hepatic fat: A novel marker for high-risk coronary atherosclerosis in Familial Hypercholesterolaemia.
Judges: Matthew Worthley, Liza Thomas
PhD Candidate Poster Prize
Winner: Himawan Fernando, Alfred Health
Title: LidocAine Versus Opioids In MyocarDial infarction: The AVOID-2 randomised controlled trial.
Judges: Clara Chow, Will Parsonage
Cardiovascular Nursing Poster Prize
Winner: Nathan Herbert, Barwon Health
Title: Impact of COVID-19 pandemic lockdown on a Victorian regional ST-elevation myocardial infarction service.
Judges: Caleb Ferguson, Rochelle Wynne
Allied Health, Science and Technology Poster Prize
Winner: Clara Zwack, University of Sydney
Stress and its relationship to cardiovascular risk in young adults with intellectual disability
Judges: Lee Nedkoff, Stacey Nielson
Congratulations to all finalists in the prize sessions and thank you to all the judges.
2022 RT Hall Prize winner at CSANZ ASM – Prof Gerald Watts
The RT Hall Prize is the most prestigious research award of CSANZ and recognises the achievements of senior and established investigators.
The 2022 R T Hall Prize is awarded to Prof Gerald Watts.
Professor Watts is the Winthrop Professor of Cardiometabolic and Internal Medicine at the University of Western Australia and Senior Consultant Physician at the Royal Perth Hospital.
Over the course of the last 25 years he has established a globally recognised translational research program in Perth, which has extended his fundamental interest in dyslipidaemia and diabetes to developing world class models in health service delivery. He published the seminal paper outlining the importance of lipid lowering in the regression of angiographic disease in an era prior to the use of more advanced arterial wall imaging. His work has enabled a fundamental understanding of the clinical and pharmacological factors that influence lipoprotein metabolism and he has played a pivotal role in the early development of a number of novel therapies that target cardiometabolic risk. In recent years, he has led national efforts to develop effective, multidisciplinary clinical models of care for familial hypercholesterolaemia and associated research and training initiatives.